{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T18:31:15Z","timestamp":1777660275965,"version":"3.51.4"},"reference-count":24,"publisher":"SAGE Publications","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["HAB"],"published-print":{"date-parts":[[2019,2,18]]},"DOI":"10.3233\/hab-170327","type":"journal-article","created":{"date-parts":[[2017,10,13]],"date-time":"2017-10-13T12:14:34Z","timestamp":1507896874000},"page":"103-111","source":"Crossref","is-referenced-by-count":5,"title":["Obtaining and characterization of monoclonal antibodies against recombinant extracellular domain of human epidermal growth factor receptor 2"],"prefix":"10.1177","volume":"26","author":[{"given":"Nurgul","family":"Sarina","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sailau","family":"Abeldenov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aigerim","family":"Turgimbayeva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Assylbek","family":"Zhylkibayev","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yerlan","family":"Ramankulov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bekbolat","family":"Khassenov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saule","family":"Eskendirova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","reference":[{"key":"10.3233\/HAB-170327_ref1","doi-asserted-by":"crossref","first-page":"12","DOI":"10.11134\/btp.1.2014.2","article-title":"Cloning, expression and purification of recombinant analog of Taq DNA polymerase","volume":"1","author":"Abeldenov","year":"2014","journal-title":"Biotechnology. Theory and Practice"},{"issue":"8","key":"10.3233\/HAB-170327_ref2","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1093\/clinchem\/48.8.1314","article-title":"Relationship of serum HER-2\/neu and serum CA 15-3 in patients with metastatic breast cancer","volume":"48","author":"Ali","year":"2002","journal-title":"Clin Chem"},{"key":"10.3233\/HAB-170327_ref3","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1093\/annonc\/mdg365","article-title":"Novel therapeutic strategies targeting the epidermal growth factor receptor (EGFR) family and its downstream effectors in breast cancer","volume":"14","author":"Atalay","year":"2003","journal-title":"Ann. Oncol"},{"issue":"2","key":"10.3233\/HAB-170327_ref4","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/0167-4838(87)90112-9","article-title":"On the tertiary structure of the extracellular domains of the epidermal growth factor and insulin receptors","volume":"916","author":"Bajaj","year":"1987","journal-title":"Biochim Biophys Acta"},{"issue":"5","key":"10.3233\/HAB-170327_ref5","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.breast.2014.06.011","article-title":"Co-overexpression of HER2\/HER3 is a predictor of impaired survival in breast cancer patients","volume":"23","author":"Berghoff","year":"2014","journal-title":"Breast"},{"key":"10.3233\/HAB-170327_ref6","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/0003-2697(76)90527-3","article-title":"A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding","volume":"72","author":"Bradford","year":"1976","journal-title":"Anal Biochem"},{"key":"10.3233\/HAB-170327_ref7","doi-asserted-by":"crossref","first-page":"31","DOI":"10.4137\/BIC.S12389","article-title":"Circulating HER2 Extracellular Domain: A Specific and Quantitative Biomarker of Prognostic Value in all Breast Cancer Patients","volume":"5","author":"Carney","year":"2013","journal-title":"Biomark Cancer"},{"issue":"6924","key":"10.3233\/HAB-170327_ref8","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1038\/nature01392","article-title":"Structure of the extracellular region of HER2 alone and in complex with the Herceptin Fab","volume":"421","author":"Cho","year":"2003","journal-title":"Nature"},{"issue":"1","key":"10.3233\/HAB-170327_ref9","first-page":"285","article-title":"Antibody production by hybridoma","volume":"39","author":"Coding","year":"1980","journal-title":"J. Immunol. Meth"},{"issue":"4730","key":"10.3233\/HAB-170327_ref10","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1126\/science.2999974","article-title":"Tyrosine kinase receptor with extensive homology to EGF receptor shares chromosomal location with neu oncogene","volume":"230","author":"Coussens","year":"1985","journal-title":"Science"},{"key":"10.3233\/HAB-170327_ref11","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.ejca.2015.10.066","article-title":"Genetic variants in the HER2 gene: Influence on HER2 overexpression and loss of heterozygosity in breast cancer","volume":"55","author":"Cresti","year":"2016","journal-title":"Eur J Cancer"},{"issue":"8","key":"10.3233\/HAB-170327_ref12","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1158\/1055-9965.EPI-13-1170","article-title":"Imaging features of HER2 overexpression in breast cancer: a systematic review and meta-analysis","volume":"23","author":"Elias","year":"2014","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.3233\/HAB-170327_ref13","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/S1535-6108(04)00083-2","article-title":"Insights into ErbB signaling from the structure of the ErbB2-pertuzumab complex","volume":"5","author":"Franklin","year":"2004","journal-title":"Cancer Cell"},{"key":"10.3233\/HAB-170327_ref14","unstructured":"R. Simon, Molecular Diagnostics for Predicting and Monitoring Therapeutic Effect, in: Biomarkers in Breast Cancer, G. Gasparini and D. Hayes, eds, Humana Press Ink, Totowa, NJ, 2007, pp. 333."},{"issue":"1","key":"10.3233\/HAB-170327_ref15","doi-asserted-by":"crossref","first-page":"55","DOI":"10.5858\/2010-0454-RAR.1","article-title":"HER2: biology, detection, and clinical implications","volume":"135","author":"Gutierrez","year":"2011","journal-title":"Arch Pathol Lab Med"},{"issue":"5259","key":"10.3233\/HAB-170327_ref16","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1038\/227680a0","article-title":"Cleavage of structural proteins during the assembly of the head of bacteriophage T4","volume":"227","author":"Laemmli","year":"1970","journal-title":"Nature"},{"issue":"5","key":"10.3233\/HAB-170327_ref17","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.ccr.2004.09.027","article-title":"Upregulation of CXCR4 is essential for HER2-mediated tumor metastasis","volume":"6","author":"Li","year":"2004","journal-title":"Cancer Cell"},{"issue":"3","key":"10.3233\/HAB-170327_ref18","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/j.ijrobp.2003.06.002","article-title":"Signal transduction and oncogenesis by ErbB\/HER receptors","volume":"58","author":"Marmor","year":"2004","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.3233\/HAB-170327_ref20","doi-asserted-by":"crossref","first-page":"42","DOI":"10.11134\/btp.2.2014.6","article-title":"Purification of recombinant Pfu DNA polymerase by double step affinity chromatography","volume":"2","author":"Mussakhmetov","year":"2014","journal-title":"Biotechnology. Theory and Practice"},{"key":"10.3233\/HAB-170327_ref21","unstructured":"V.T. Oi and L.A. Herzenberg, Immunoglobulin- producing hybrid cell lines, in: Selected Methods in Cellular Immunology, B.B. Mishell and S.M. Shiigi, eds, W.H. Freeman New York, 1980, pp. 351\u2013352."},{"issue":"3\u20134","key":"10.3233\/HAB-170327_ref22","first-page":"163","article-title":"Serum HER-2 extracellular domain (ECD) before the first metastasis in 128 breast cancer patients","volume":"50","author":"Pichon","year":"2004","journal-title":"Clin Lab."},{"key":"10.3233\/HAB-170327_ref23","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1634\/theoncologist.2009-0145","article-title":"Targeting signal transduction pathways in metastatic breast cancer: a comprehensive review","volume":"15","author":"Rosen","year":"2010","journal-title":"Oncologist"},{"issue":"3","key":"10.3233\/HAB-170327_ref24","doi-asserted-by":"crossref","first-page":"180","DOI":"10.5230\/jgc.2014.14.3.180","article-title":"Correlation between HER2 Overexpression and Clinicopathological Characteristics in Gastric Cancer Patients Who Have Undergone Curative Resection","volume":"14","author":"Son","year":"2014","journal-title":"J Gastric Cancer"},{"issue":"8","key":"10.3233\/HAB-170327_ref25","doi-asserted-by":"crossref","first-page":"e2803","DOI":"10.1097\/MD.0000000000002803","article-title":"Prognostic Value of KIF2A and HER2-Neu Overexpression in Patients With Epithelial Ovarian Cancer","volume":"95","author":"Wang","year":"2016","journal-title":"Medicine (Baltimore)"}],"container-title":["Human Antibodies"],"original-title":[],"link":[{"URL":"https:\/\/content.iospress.com\/download?id=10.3233\/HAB-170327","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T07:22:02Z","timestamp":1777447322000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/full\/10.3233\/HAB-170327"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,18]]},"references-count":24,"journal-issue":{"issue":"2"},"URL":"https:\/\/doi.org\/10.3233\/hab-170327","relation":{},"ISSN":["1875-869X","1093-2607"],"issn-type":[{"value":"1875-869X","type":"electronic"},{"value":"1093-2607","type":"print"}],"subject":[],"published":{"date-parts":[[2019,2,18]]}}}